June 2003

Biotech Life-Cycle Management

April 17, 2008

10 J u n e 20 03 PharmaVOICE THE MANAGEMENTTEAM … CAROLCHERKIS,PH.D. Life sciences consultant,NewCap Partners Inc., Los Angeles; NewCap Partners is a private investment banking firm that focuses on the finance needs of middlemarket companies.For more information, visit newcap.com. TILLMAN U.GERNGROSS,PH.D. Chief scientific officer, GlycoFi Inc., Lebanon,N.H.; GlycoFi is developing technology to address the […]

An Inquiring Mind: The Pursuit of Knowledge

April 17, 2008

AN INQUIRING MIND: The Pursuit of Knowledge FROM ACADEMIA TO GOVERNMENT SPONSORED PROGRAMS TOTHE PHARMACEUTICAL INDUSTRY, JONATHANKNOWLES,PH.D., BRINGS TO ROCHE A FOCUSED PERSPECTIVE ONTHE UNIVERSAL POWER OF GOOD SCIENCE,WHICH IS HELPING TO STEER THE COMPANY’S DUAL DIAGNOSTIC AND PHARMACEUTICAL APPROACH TO MEDICINE. BY KIM RIBBINK 51 PharmaVOICE J un e 2 00 3 JONATHAN Knowles […]

How 5/19 Changed the Industry Forever

April 17, 2008

46 J u n e 20 03 PharmaVOICE n the past two decades, the companies involved in this story have long since changed, casual ties of multiple mergers and acquisitions. But the genesis of DTC advertising can be traced back to Boots Pharmaceuticals, a small Europeanbased pharmaceutical company. While directtophysician ads appeared in print first […]

The Emergence of the Bioscience Cluster

April 16, 2008

36 J un e 2 003 PharmaVOICE ll drug development is local, to borrow from a popular phrase. Although pharma and biotech companies have to be focused on global issues, they still are firmly rooted in the commu nities in which they reside. State and local governments recognize the benefits to the local economic environment […]

Striking a Balance for Innovation

April 16, 2008

26 J u n e 20 03 PharmaVOICE INNOVATION Striking a Balance for BY DENISE MYSHKO Recently proposed regulations strive to restore the balance between protecting the intellectual assets related to innovation by pharmaceutical manufacturers and the opportunity to bring lowercost generic products to market by nonbrand manufacturers. F For hundreds of years, patents protecting […]

Talent Pool

April 16, 2008

80 J u n e 20 03 PharmaVOICE Pharma POOL Dr. Catherine BONUCCELLI AstraZeneca NamesVP,External Scientific Affairs Catherine Bonuccelli, M.D., has been promoted to the position of VP of external scientific affairs at AstraZeneca, Wilm ington, Del. Dr. Bonuc celli is responsible for building and sustaining relationships with health care customers, including managedcare com panies, […]

E-Media

April 16, 2008

76 J u n e 20 03 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Choice Media has expanded its health newscov erage through an agreement with Ivanhoe Broad cast News, a newsgathering organization covering medical information for television stations. The rela tionship provides Ivanhoe’s health news across the entire Choice Media Network […]

What’s New

April 16, 2008

PharmaVOICE WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Carbon Healthcare Communications, a new division of CommonHealth,has been launched as a professional advertising and promotion agency to serve the needs of “highscience”brands. The agen cy is targeting biopharmaceutical and emerging companies as well as prod ucts for special populationssuchaschil dren, the elderly, and immunocompro mised […]

PharmaTrax

April 16, 2008

66 J u n e 20 03 PharmaVOICE PHARMA TRAX SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY 56 MILLION U.S. ADULTS GOONLINE for Information on Chronic Health Conditions Data gathered by Manhattan Research LLC’s ePharma Analytical Insight Module (AIM) reveals that 56.3 million U.S. adults go online to gather informa tion about chronic […]

For Art’s Sake

April 16, 2008

Creative Review Advertising campaign for Allegra represents an original and refreshing approach to the patient type challenge. In a welcome departure from the tradi tional patientinyourface approach, it uses a variety of different vehicles and complementing hats that clearly say Allegra is for a wide range of seasonal allergy patients. In addition,the attentiongetting vehicles and […]

PharmaOutlet

April 16, 2008

The marketplace is fast approaching 100,000 sales representatives, and reports in The Wall Street Journal suggest that physicians aren’t influenced by what representatives are saying. The question is: Why are there so many reps who can’t seem to get their message across? Adding more representatives doesn’t seem to be the answer. The answer may lie […]

PharmaCase

April 16, 2008

Common to many nonprofits is the develop ment of national publiceducation initiatives or cam paigns to enhance awareness about particular health issues. Often,these campaigns are supported by educational grants from pharmaceutical compa nies. Partnerships with nonprofits are important to pharmaceutical companies for many reasons, including providing “thirdparty credibility” and access to target audiences. Having worked […]

Opinions

April 16, 2008

6 J un e 20 03 PharmaVOICE WHAT’S on your mind Breadth and depth I find that industry associations do an excellent job in providing networking, pro fessional continuing education, industry rela tions, and businessdevelopment resources. I can’t speak highly enough about the breadth and depth of opportunity that industry asso ciations provide to professionals. […]

Letter from the Editor

April 16, 2008

3 PharmaVOICE J un e 2003 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, Number Six PharmaVOICE is published 12 times per year […]

FEEDBACK